An intervention to improve the quality of emergency care during childbirth in Nigeria
ISRCTN | ISRCTN17985403 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN17985403 |
Secondary identifying numbers | A65869, NCTR91540209 |
- Submission date
- 03/08/2020
- Registration date
- 14/08/2020
- Last edited
- 17/09/2024
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Pregnancy and Childbirth
Plain English summary of protocol
Background and study aims
Along with India, Nigeria currently accounts for one-third of the annual maternal deaths in the world. Among several other factors, poor quality of care and the inadequate use of skilled care for pregnant women are the key determinants of the high rate of maternal deaths in Nigeria.
The intervention was designed to improve the quality of care, and patient satisfaction and to reduce deaths of mothers and children during pregnancy and childbirth in Nigeria.
Who can participate?
Pregnant women who access maternal care in participating centers and their health care givers
What does the study involve?
Of the 8 hospitals involved in the study, the intervention was carried out in 4. The intervention activities include structured training in improving maternal outcomes, strategic planning and monitoring, and gathering patient feedback. During the study period data was collected from all 8 hospitals on maternal outcomes to compare between the hospitals that received the intervention and those that did not.
What are the possible benefits and risks of participating?
None
Where is the study run from?
The Women’s Health and Research Centre, Bénin City (Nigeria)
When is the study starting and how long is it expected to run for?
July 2017 to July 2019
Who is funding the study?
World Health Organisation (Switzerland)
Who is the main contact?
Prof. Friday Okonofua, feokonofua@yahoo.co.uk
Contact information
Scientific
KM 11, Lagos-Benin Expressway
Igue-Iheya
Benin City
301000
Nigeria
0000-0002-8777-2606 | |
Phone | +234 8023347828 |
feokonofua@wharc-online.org |
Scientific
University of Port Harcourt
Port Harcourt
500272
Nigeria
0000-0002-5467-302X | |
Phone | +234 8033129937 |
rosemary.ogu@uniport.edu.ng |
Study information
Study design | Multi-centre interventional quasi-experimental mixed-methods study |
---|---|
Primary study design | Interventional |
Secondary study design | Quasi-experimental mixed-methods study |
Study setting(s) | Hospital |
Study type | Other |
Participant information sheet | Not available in web format, please use the contact details below to request a patient information sheet |
Scientific title | Intervention to improve the quality of emergency obstetric care for preventing maternal and perinatal mortality in referral hospitals in Nigeria: a quasi-experimental research study |
Study objectives | 1.There is no significant difference in the policies and patterns of emergency obstetric care and practices between intervention and control health facilities 2. There is no significant difference in the clinical management of the complications that lead to maternal/perinatal deaths between the intervention and control health facilities 3. There is no significant difference in the assessments of the quality of clinical care between intervention and control sites 4. There is no significant difference in case-fatality rates due to leading obstetric complications between intervention and control sites 5. There is no significant difference in the indicators of maternal and newborn outcomes (maternal, stillbirth, and neonatal death ratios) between the intervention and control health facilities |
Ethics approval(s) | 1. Approved 25/06/204, WHO Research Ethics Review Committee (20 Avenue Appia-CH-1211 Geneva 27, Switzerland; no telephone number provided; ercsec@who.int), ref: A65869. 2. Approved 16/07/2014, National Health Research Ethics Committee (NHREC) of Nigeria (Federal Ministry of Health, Federal Secretariat, Abuja, Nigeria; +234-9-523-8367; info@nhrec.net), ref: NHREC/01/01/2007 – renewed in 2015, ref: NHREC 01/01/20047-12/12/2015b |
Health condition(s) or problem(s) studied | Emergency obstetric care |
Intervention | All the women who presented for antenatal, delivery and postnatal care within the period were eligible for inclusion in the study. Recruitment and informed consent were obtained at the time the women registered in the hospitals for antenatal care, or during admission for management of complications, or at the time of delivery. Informed consent was obtained from those presenting with pregnancy related complications when they have been clinically stabilized. For women presenting at the hospital for the first time in labour, consent is obtained after they delivered their babies. The monitoring/evaluation officer collects and enters the data into the computer system daily. Sources of data collection were hospital records, clinical case records, maternal/perinatal deaths clinical audit records, maternal/perinatal death reviews, client flow analysis, focus group discussion, in-depth interview, and exit interviews. Total duration of observation is the total time the woman spends at the facility. Six public secondary care hospitals and two public tertiary care hospitals in both north and south of Nigeria were selected randomly for the formative phase. Thereafter the intervention was carried out in four of the initial eight hospitals, with two hospitals as intervention and two as control sites. At baseline, we assessed the providers’ and facilities’ readiness to provide care, patients' satisfaction and experience while accessing obstetric care, using a mixed-method which included a questionnaire on knowledge and management of obstetric complications, site inventory assessment, client flow analysis, focus group discussion and in-depth interviews. The intervention activities which were developed based on the results in the formative research include 1. Development of a strategic plan for preventing maternal and perinatal deaths 2. Staff Training/Capacity building for healthcare providers in the facilities 3. Establishing a maternal and perinatal death surveillance and response system (MPDSR) in the health facilities 4. Development of protocols, guidelines, algorithm and reminders for clinical Emergency Obstetric Care EmOC 5. Advocacy activities for increased funding and resource mobilization 6. Computerized appointment scheduling system to reducing delays in service delivery 7. Patients education and feedback- Involving men in maternal and child health care through monthly health talk |
Intervention type | Mixed |
Primary outcome measure | Measured at baseline, monthly during the intervention, and at endline using patient records: 1. Number of women attending antenatal, delivery and post-natal clinics 2. Women with moderate to severe PPH, eclampsia, and obstructed labour 3. Number of cases with PPH, eclampsia and obstructed labour where internationally accepted protocols are adhered to or breeched 4. Number of clinically managed cases of PPH, eclampsia and obstructed that died 5. Number of maternal deaths 6. Number of stillbirths and early neonatal deaths occurring in the hospitals |
Secondary outcome measures | Client perception of quality and satisfaction with care measured using client flow analysis (patient records) at baseline, monthly during the intervention, and at endline and also by an exit interview questionnaire |
Overall study start date | 01/07/2017 |
Completion date | 30/07/2019 |
Eligibility
Participant type(s) | Mixed |
---|---|
Age group | Adult |
Sex | Both |
Target number of participants | 18,000 patient records reviewed and 2,400 interviewed |
Total final enrolment | 20439 |
Key inclusion criteria | 1. Pregnant women that present during the intervention period 2. All the healthcare givers in the obstetric units |
Key exclusion criteria | Does not meet inclusion criteria |
Date of first enrolment | 01/10/2017 |
Date of final enrolment | 30/06/2019 |
Locations
Countries of recruitment
- Nigeria
Study participating centres
301000
Nigeria
-
Nigeria
-
Nigeria
-
Nigeria
Sponsor information
Research council
20 Avenue Appia-CH-1211
Geneva
CH1211
Switzerland
Phone | +41 22 791 3791 |
---|---|
ercsec@who.int | |
Website | https://www.WHO.INT.RPC/Research_Ethics |
https://ror.org/01f80g185 |
Funders
Funder type
Research organisation
Private sector organisation / International organizations
- Alternative name(s)
- منظمة الصحة العالمية, 世界卫生组织, Всемирная организация здравоохранения, Organisation mondiale de la Santé, Organización Mundial de la Salud, WHO, 世卫组织, ВОЗ, OMS
- Location
- Switzerland
Results and Publications
Intention to publish date | 30/10/2020 |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Stored in repository |
Publication and dissemination plan | Data repository Publication in high impact journals Policy document |
IPD sharing plan | The datasets generated during and/or analysed during the current study will be stored in a publically available repository. The datasets generated during the formative phase of this study is stored on Zenodo (http://doi.org/10.5281/zenodo.161549). Users are expected to request for access from the Principal Investigator, Professor Friday Okonofua Email feokonofua@yahoo.co.uk. The intervention datasets will also be stored on Zenodo and will be available on request from the principal Investigator. The qualitative data are outputs generated from a computer-assisted qualitative data analysis software, Atlas.ti version 6.25, whereas the quantitative data are all stored in SPSS format. There are no legal issues, and no consent to share is required from the participants. |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Results article | Effects on rates of primary postpartum haemorrhage (PPH) | 01/04/2022 | 17/08/2022 | Yes | No |
Results article | Results of exit interviews with mothers | 26/08/2023 | 29/08/2023 | Yes | No |
Results article | improving six quality indicators | 04/11/2020 | 17/09/2024 | Yes | No |
Editorial Notes
17/09/2024: Publication reference added.
29/08/2023: The following changes have been made:
1. Publication reference added.
2. The NCTR number has been added from the reference
17/08/2022: Publication reference added.
14/08/2020: Internal review.
12/08/2020: Trial’s existence confirmed by the World Health Organization.